on VIRBAC (EPA:VIRP)
Virbac appoints Paul Martingell as CEO from September 2025
Virbac, a company specializing in animal health, has announced the appointment of Paul Martingell as its new Chief Executive Officer, effective September 1, 2025. Martingell, 45, has over 25 years of experience in consumer healthcare, consumer goods, and pharmaceuticals.
His career includes international leadership roles at Ernst & Young, Reckitt Benckiser, and Novartis Consumer Healthcare. His recent experience includes leading major regions as Senior Vice President for Europe and Latin America.
Marie-Hélène Dick, Chair of Virbac's Board of Directors, expressed her confidence in Martingell, highlighting his leadership and ability to take on new challenges. Paul Martingell will succeed Habib Ramdani, who has been serving in the interim role.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VIRBAC news